Progress in the epidemiological understanding of gene-environment interactions in major diseases: cancer

Comptes Rendus - Biologies

Volumn 330, Issue 4, 2007, Pages 306-317

  Clavel, Jacqueline ^a  

^a INSERM   (France)

Author keywords

Cancer; Environment; Epidemiology; Gene; Interaction; Review

Indexed keywords

CARCINOGEN; PROTEIN; XENOBIOTIC AGENT;

CANCER; CARCINOGEN; EPIDEMIOLOGY; GENE;

BIOINFORMATICS; BLADDER CANCER; CANCER; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CARCINOGENESIS; DATA BASE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; GENETIC SCREENING; GENOTYPE; HEREDITY; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LARYNX CANCER; LUNG CANCER; METHODOLOGY; MULTIVARIATE ANALYSIS; SAMPLING; SHORT SURVEY; SMOKING; STATISTICAL ANALYSIS; TISSUE REPAIR; WORK ENVIRONMENT;

CARCINOGENS; ENVIRONMENT; FRANCE; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; MODELS, GENETIC; NEOPLASMS; POLYMORPHISM, GENETIC; SMOKING; TRANSCRIPTION, GENETIC;

EID: 34248214645     PISSN: 16310691     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crvi.2007.02.012     Document Type: Short Survey

References (21)

1. Cartwright R.A., Glashan R.W., Rogers H.J., Ahmad R.A., Barham-Hall D., Higgins E., and Kahn M.A. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 2 8303 (1982) 842-845
2. Gaspari L., Marinelli D., and Taioli E. Collaborative Group on Genetic Susceptibility to Environmental Carcinogens. International collaborative study on genetic susceptibility to environmental carcinogens (GSEC): an update. Int. J. Hyg. Environ. Health 204 1 (2001) 39-42
3. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., Baranova H., Bathum L., Benhamou S., Boffetta P., Bouchardy C., Breskvar K., Brockmoller J., Cascorbi I., Clapper M.L., Coutelle C., Daly A., Dell'Omo M., Dolzan V., Dresler C.M., Fryer A., Haugen A., Hein D.W., Hildesheim A., Hirvonen A., Hsieh L.L., Ingelman-Sundberg M., Kalina I., Kang D., Kihara M., Kiyohara C., Kremers P., Lazarus P., Le Marchand L., Lechner M.C., van Lieshout E.M., London S., Manni J.J., Maugard C.M., Morita S., Nazar-Stewart V., Noda K., Oda Y., Parl F.F., Pastorelli R., Persson I., Peters W.H., Rannug A., Rebbeck T., Risch A., Roelandt L., Romkes M., Ryberg D., Salagovic J., Schoket B., Seidegard J., Shields P.G., Sim E., Sinnet D., Strange R.C., Stucker I., Sugimura H., To-Figueras J., Vineis P., Yu M.C., and Taioli E. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 10 12 (2001) 1239-1248
4. Le Marchand L., Guo C., Benhamou S., Bouchardy C., Cascorbi I., Clapper M.L., Garte S., Haugen A., Ingelman-Sundberg M., Kihara M., Rannug A., Ryberg D., Stücker I., Sugimura H., and Taioli E. Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control. 14 4 (2003) 339-346
5. Vineis P., Marinelli D., Autrup H., Brockmoller J., Cascorbi I., Daly A.K., Golka K., Okkels H., Risch A., Rothman N., Sim E., and Taioli E. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol. Biomarkers Prev. 10 12 (2001) 1249-1252
6. Brennan P., Lewis S., Hashibe M., Bell D.A., Boffetta P., Bouchardy C., Caporaso N., Chen C., Coutelle C., Diehl S.R., Hayes R.B., Olshan A.F., Schwartz S.M., Sturgis E.M., Wei Q., Zavras A.I., and Benhamou S. Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. Am. J. Epidemiol. 159 1 (2004) 1-16
7. Hashibe M., Boffetta P., Zaridze D., Shangina O., Szeszenia-Dabrowska N., Mates D., Janout V., Fabiánová E., Bencko V., Moullan N., Chabrier A., Hung R., Hall J., Canzian F., and Brennan P. Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev. 15 4 (2006) 696-703
8. Benhamou S., and Sarasin A. ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review. Am. J. Epidemiol. 161 1 (2005) 1-14
9. Manuguerra M., Saletta F., Karagas M.R., Berwick M., Veglia F., Vineis P., and Matullo G. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am. J. Epidemiol. 164 4 (2006) 297-302
10. Hung R.J., Hall J., Brennan P., and Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am. J. Epidemiol. 162 10 (2005) 925-942
11. Hayward N.K. Genetics of melanoma predisposition. Oncogene 22 20 (2003) 3053-3062
12. Bishop D.T., Demenais F., Goldstein A.M., Bergman W., Bishop J.N., Bressac-de Paillerets B., Chompret A., Ghiorzo P., Gruis N., Hansson J., Harland M., Hayward N., Holland E.A., Mann G.J., Mantelli M., Nancarrow D., Platz A., and Tucker M.A. Melanoma Genetics Consortium. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J. Natl Cancer Inst. 94 12 (2002) 894-903
13. Chaudru V., Laud K., Avril M.-F., Minière A., Chompret A., Bressac-de Paillerets B., and Demenais F. Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees. Cancer Epidemiol. Biomarkers Prev. 14 10 (2005) 2384-2390
14. Vineis P., Veglia F., Anttila S., Benhamou S., Clapper M.L., Dolzan V., Ryberg D., Hirvonen A., Kremers P., Le Marchand L., Pastorelli R., Rannug A., Romkes M., Schoket B., Strange R.C., Garte S., and Taioli E. CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene-gene interactions. Biomarkers 9 3 (2004) 298-305
15. Hashibe M., Brennan P., Strange R.C., Bhisey R., Cascorbi I., Lazarus P., Oude Ophuis M.B., Benhamou S., Foulkes W.D., Katoh T., Coutelle C., Romkes M., Gaspari L., Taioli E., and Boffetta P. Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol. Biomarkers Prev. 12 12 (2003) 1509-1517
16. García-Closas M., Malats N., Silverman D., Dosemeci M., Kogevinas M., Hein D.W., Tardón A., Serra C., Carrato A., García-Closas R., Lloreta J., Castaño-Vinyals G., Yeager M., Welch R., Chanock S., Chatterjee N., Wacholder S., Samanic C., Torà M., Fernández F., Real F.X., and Rothman N. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366 9486 (2005) 649-659
17. Vineis P., Veglia F., Benhamou S., Butkiewicz D., Cascorbi I., Clapper M.L., Dolzan V., Haugen A., Hirvonen A., Ingelman-Sundberg M., Kihara M., Kiyohara C., Kremers P., Le Marchand L., Ohshima S., Pastorelli R., Rannug A., Romkes M., Schoket B., Shields P., Strange R.C., Stucker I., Sugimura H., Garte S., Gaspari L., and Taioli E. CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int. J. Cancer 104 5 (2003) 650-657
18. Benhamou S., Lee W.J., Alexandrie A.K., Boffetta P., Bouchardy C., Butkiewicz D., Brockmöller J., Clapper M.L., Daly A., Dolzan V., Ford J., Gaspari L., Haugen A., Hirvonen A., Husgafvel-Pursiainen K., Ingelman-Sundberg M., Kalina I., Kihara M., Kremers P., Le Marchand L., London S.J., Nazar-Stewart V., Onon-Kihara M., Rannug A., Romkes M., Ryberg D., Seidegard J., Shields P., Strange R.C., Stücker I., To-Figueras J., Brennan P., and Taioli E. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 23 8 (2002) 1343-1350
19. Ye Z., Song H., Higgins J.P., Pharoah P., and Danesh J. Five glutathione S-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med. 3 4 (2006) e91
20. Engel L.S., Taioli E., Pfeiffer R., Garcia-Closas M., Marcus P.M., Lan Q., Boffetta P., Vineis P., Autrup H., Bell D.A., Branch R.A., Brockmöller J., Daly A.K., Heckbert S.R., Kalina I., Kang D., Katoh T., Lafuente A., Lin H.J., Romkes M., Taylor J.A., and Rothman N. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am. J. Epidemiol. 156 2 (2002) 95-109
21. Raimondi S., Boffetta P., Anttila S., Bröckmoller J., Butkiewicz D., Cascorbi I., Clapper M.L., Dragani T.A., Garte S., Gsur A., Haidinger G., Hirvonen A., Ingelman-Sundberg M., Kalina I., Lan Q., Leoni V.P., Le Marchand L., London S.J., Neri M., Povey A.C., Rannug A., Reszka E., Ryberg D., Risch A., Romkes M., Ruano-Ravina A., Schoket B., Spinola M., Sugimura H., Wu X., and Taioli E. Metabolic gene polymorphisms and lung cancer risk in non-smokers, An update of the GSEC study. Mutat. Res. 592 1-2 (2005) 45-57